
- What is Rymti?
- Indications and Benefits of Rymti
- Rymti Drug Information
- How It Works
- Rymti Dosage
- Usage Guide
- Rymti Side Effects
- Missed Dose
- Overdose
- Storage Information
- Rymti Warnings
- Contraindications
- Interactions
- Alternatives
- Buy Rymti Online From Canada: Cost & Coupons
- Frequently Asked Questions
- Disclaimer
- Price Match Guarantee
What is Rymti?
Rymti (etanercept) is a prescription treatment that helps calm an overactive immune system. It belongs to a group of treatments called tumor necrosis factor (TNF) blockers, which work by reducing inflammation, swelling, pain, and stiffness in the body.
Rymti is FDA-approved to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and juvenile idiopathic arthritis in certain children.
Patients looking for Rymti in Canada often use it to help improve movement and daily physical function.
Rymti is typically prescribed to adults and children with moderate to severe inflammatory conditions that have not improved enough with other treatments.
Rheumatoid arthritis is a condition where the immune system attacks the joints, while plaque psoriasis causes thick, red, scaly skin patches. Rymti may help reduce joint damage, skin symptoms, and ongoing discomfort caused by these long-term conditions.
Indications and Benefits of Rymti
Rymti is approved to help manage several long-term inflammatory conditions that affect the joints, skin, and immune system.
FDA-Approved Indications
- Rymti is approved for adults with moderate to severe rheumatoid arthritis to help reduce joint pain, swelling, stiffness, and physical limitations.
- It is also used for psoriatic arthritis to improve joint symptoms and help slow joint damage progression.
- Rymti is approved for ankylosing spondylitis, a condition that causes inflammation and stiffness in the spine.
- Adults with chronic moderate to severe plaque psoriasis may use Rymti when light therapy or whole-body treatment is needed.
- Children ages 4 to 17 with polyarticular juvenile idiopathic arthritis or severe plaque psoriasis may also be treated with Rymti in certain cases.
Key Clinical Benefits
- Some adults reported symptom improvement as early as 1 week after starting treatment.
- Children with juvenile idiopathic arthritis showed improvement within about 2 weeks in clinical studies.
- Psoriasis symptoms, including redness and scaling, improved within approximately 4 weeks for many patients.
- Continued treatment helped maintain symptom control and improve physical function over time.
Common Off-Label Uses
- Some healthcare providers may prescribe etanercept products off-label for conditions such as Crohn’s disease or ulcerative colitis, although these uses are not officially approved for Rymti.
Rymti Drug Information
| Category | Details |
| Brand Name | Rymti |
| Generic Name | etanercept |
| Medication Class | Tumor necrosis factor blocker, also called a TNF blocker. It helps lower inflammation caused by an overactive immune system. |
| Primary Use | Rymti is used for moderate to severe rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. |
| Additional Uses / Off-Label | Off-label use should only be decided by a doctor. Rymti is not listed for Crohn’s disease or ulcerative colitis in the provided labeling. |
| Available Form | Injection solution in a single-use prefilled syringe or single-use prefilled autoinjector. |
| Method of Administration | Injected under the skin. |
| Available Dosage Strengths | 25 mg per 0.5 mL prefilled syringe, 50 mg per 1 mL prefilled syringe, and 50 mg per 1 mL autoinjector. |
| Dosing Frequency | For RA, PsA, and AS, adults usually use 50 mg once weekly. For adult plaque psoriasis, the starting dose is 50 mg twice weekly for 3 months, then 50 mg once weekly. Pediatric dosing is based on body weight. |
| Storage Instructions | Store in the refrigerator at 2°C to 8°C. Do not freeze. Rymti may be kept at room temperature up to 27°C for up to 60 days. Protect from direct sunlight, heat, and humidity. |
| Pregnancy & Breastfeeding | Safe use during pregnancy has not been established. Rymti can pass into breast milk, and the effects on nursing babies are not known. Patients should talk to a doctor before use. |
| Major Drug Interactions | Anakinra, abatacept, cyclophosphamide, live vaccines, and diabetes treatments that may need dose adjustment. |
| Manufacturer | Lupin Pharma Canada Inc. |
How It Works
Rymti works by blocking a substance in the body called tumor necrosis factor alpha, also known as TNF-alpha.
This substance is part of the immune system and normally helps the body fight infection. In some autoimmune conditions, the body produces too much TNF-alpha, which can lead to ongoing inflammation, joint pain, swelling, stiffness, and skin irritation.
Rymti helps lower these abnormal inflammation signals so the immune system becomes less aggressive toward the joints and skin.
By reducing inflammation, Rymti may help improve movement, reduce pain, and slow joint damage over time. Many adults begin noticing symptom improvement within 1 to 2 weeks, although full benefits may take up to 3 months with continued treatment.
In children with juvenile idiopathic arthritis and patients with plaque psoriasis, improvement may also appear within the first few weeks.
Continued use is often needed to help maintain long-term symptom control and physical function.
Rymti Dosage
Rymti comes as a solution for injection in prefilled syringes and autoinjector pens. The available strengths include 25 mg and 50 mg options.
Children who require weight-based dosing below 63 kg may need another etanercept product that allows more accurate dose adjustment.
The correct Rymti dose depends on the condition being treated, the patient’s age, and body weight in children.
What Dosage Strengths Does Rymti Come In?
- 25 mg/0.5 mL single-use prefilled syringe
- 50 mg/1 mL single-use prefilled syringe
- 50 mg/1 mL single-use prefilled autoinjector
Dosage Chart
| Condition | Starting Dose | Maintenance Dose | Maximum Dose |
| Rheumatoid Arthritis (RA) | 50 mg once weekly | 50 mg once weekly | 50 mg per week |
| Psoriatic Arthritis (PsA) | 50 mg once weekly | 50 mg once weekly | 50 mg per week |
| Ankylosing Spondylitis (AS) | 50 mg once weekly | 50 mg once weekly | 50 mg per week |
| Adult Plaque Psoriasis (PsO) | 50 mg twice weekly for 3 months | 50 mg once weekly | 50 mg twice weekly |
| Juvenile Idiopathic Arthritis (JIA) | 0.8 mg/kg once weekly | 0.8 mg/kg once weekly | 50 mg per week |
| Pediatric Plaque Psoriasis | 0.8 mg/kg once weekly | 0.8 mg/kg once weekly | 50 mg per week |
Usage Guide
Rymti is an injectable treatment given under the skin.
Follow your doctor’s instructions carefully and ask for injection training before using it on your own.
Step-by-Step Instructions for Using Rymti
- Remove one Rymti prefilled syringe or autoinjector from the refrigerator and place it on a clean, flat surface.
- Allow it to reach room temperature for about 15 to 30 minutes before use. Do not heat it in hot water or a microwave.
- Wash your hands thoroughly with soap and warm water.
- Check the solution carefully. It should look clear and colorless. Do not use it if it appears cloudy, discolored, cracked, or contains large particles.
- Choose an injection site such as the front of the thighs, abdomen away from the belly button, or outer upper arm.
- Clean the injection area with an alcohol swab and let it dry.
- Remove the needle cover only when ready to inject. Insert the needle into the skin at a slight angle and inject slowly as instructed by your healthcare provider.
- After the injection, remove the needle and gently press the area with gauze or cotton if needed. Do not rub the skin.
- Dispose of the used syringe or pen immediately in a sharps disposal container. Never reuse needles or syringes.
Timing and Daily Use
Rymti can be used with or without food because it is not taken by mouth. Try to use it on the same day each week to help maintain consistent treatment.
Do not skip doses unless your doctor instructs you to stop treatment.
Important Things to Avoid While Using Rymti
- Do not shake the syringe or autoinjector.
- Do not freeze the product.
- Avoid injecting into bruised, red, hard, or irritated skin.
- Avoid live vaccines unless approved by your doctor.
- Tell your doctor right away if you develop signs of infection, such as fever, chills, cough, or unusual tiredness.
How to Know Rymti Is Working?
Many people notice less joint pain, stiffness, swelling, or skin irritation within the first few weeks of treatment.
Over time, Rymti may help improve movement, daily activities, and overall comfort. Continue using it exactly as prescribed, even if improvement takes several weeks.
Rymti Side Effects
Rymti can cause side effects, although many people experience mild to moderate symptoms that improve over time. Some side effects may require immediate medical attention.
| Common Side Effects | Serious Side Effects |
| Injection site reactions (Very Common):
These may include redness, swelling, itching, bruising, or mild pain where the injection was given. These reactions usually improve within 3 to 5 days. |
Serious infections (Rare):
Seek immediate medical attention if you develop fever, chills, cough, severe tiredness, shortness of breath, or signs of infection that do not improve. |
| Upper respiratory tract infections or sinus infections (Common):
Some patients may develop cold-like symptoms, congestion, or sinus discomfort during treatment. |
Tuberculosis (Rare):
Contact a doctor right away if you develop a long-lasting cough, night sweats, unexplained weight loss, or fever. |
| Headaches (Common):
Mild to moderate headaches may occur during treatment. |
Nerve disorders (Rare):
Get immediate medical help if you experience numbness, tingling, vision changes, weakness in the arms or legs, or dizziness. |
Missed Dose
If you miss a dose of Rymti, inject it as soon as you remember. After taking the missed dose, continue with your next injection at your regular scheduled time.
If it is almost time for your next scheduled dose, skip the missed dose and continue with your normal schedule.
Do not inject two doses at the same time or give extra injections to make up for a missed dose. If you are unsure when to take your next injection, contact your doctor or pharmacist for guidance.
Overdose
There is limited information about Rymti overdose, and no specific antidote is available. Symptoms may include worsening side effects such as severe injection site reactions, infections, headaches, dizziness, or unusual weakness.
If you think too much Rymti has been used, contact Poison Control right away at 1-800-222-1222 or go to the nearest emergency room immediately, even if symptoms are not present.
Bring the product packaging or prescription information with you if possible. Always use Rymti exactly as prescribed by your doctor.
Storage Information
Store Rymti in the refrigerator at 2°C to 8°C before use. Keep it in the original carton to protect it from light. Do not shake the syringe or autoinjector.
Rymti may also be stored at room temperature up to 27°C for a maximum of 60 days.
Once kept at room temperature, it must be used within 60 days and should not be returned to the refrigerator.
Protect Rymti from direct sunlight, heat, and humidity. Do not freeze the product. Keep it out of reach of children. Do not use Rymti after the expiration date printed on the carton or syringe.
Expired or unused syringes should be disposed of safely according to your pharmacist or local sharps disposal guidelines.
Rymti Warnings
FDA Black Box Warning
Serious Infections and Malignancies
Rymti may increase the risk of serious infections that can lead to hospitalization or death, including tuberculosis, sepsis, invasive fungal infections, and other opportunistic infections. Treatment should not begin in patients with active infections. Lymphoma and other cancers, including fatal cases, have been reported in children, adolescents, and young adults treated with TNF blockers such as Rymti.
Precautions
- Patients should be tested for active and latent tuberculosis before starting treatment.
- Monitor closely for signs of infection during and after treatment, including fever, cough, chills, weight loss, or unusual tiredness.
- Rymti may reactivate hepatitis B in patients with previous HBV infection.
- Serious allergic reactions, including anaphylaxis, may occur.
- Use caution in patients with congestive heart failure, especially moderate to severe cases.
- Rare blood disorders such as anemia, low white blood cell count, and pancytopenia have been reported.
- Neurologic conditions, including multiple sclerosis, seizures, optic neuritis, and Guillain-Barré syndrome, may worsen or newly occur.
- Live vaccines should not be given during treatment.
- Concurrent use with anakinra, abatacept, or cyclophosphamide is not recommended.
Patients Who Need Extra Caution
- Elderly patients due to increased infection risk
- Patients with diabetes or weakened immune systems
- Patients with a history of tuberculosis, hepatitis B, or chronic infections
- Patients with heart failure
- Patients with previous blood disorders or neurologic conditions
- Patients with a history of cancer or immunosuppressive treatment
Monitoring Requirements
- Tuberculosis screening before and during treatment
- Regular monitoring for infections and fever
- Periodic blood tests if blood disorders are suspected
- Monitoring for hepatitis B reactivation in at-risk patients
- Regular skin examinations in patients at increased risk for skin cancer
- Routine follow-up visits to monitor treatment response and side effects
Contraindications
- Rymti should not be used in patients who are allergic to etanercept or any ingredient found in the product. Serious allergic reactions may occur, including swelling, rash, or difficulty breathing.
- Patients with sepsis or those at risk for sepsis should not use Rymti. Sepsis is a severe body-wide infection that can become life-threatening. Because Rymti affects the immune system, it may increase the risk of serious infections becoming worse.
- Immunocompromised patients, including patients who are HIV positive, should generally avoid Rymti because their immune systems may already be weakened, increasing the chance of dangerous infections.
- Patients with active serious infections should not start treatment until the infection has been fully treated and cleared by a doctor.
Interactions
| Drug / Substance | What Happens | What to Do |
| Anakinra | Using Rymti with anakinra may greatly increase the risk of serious infections and low white blood cell counts. | This combination is not recommended. |
| Abatacept | Taking both treatments together may increase serious side effects without improving treatment results. | Avoid using together unless specifically directed by a specialist. |
| Cyclophosphamide | Combined use may increase the risk of certain cancers and serious complications. | Concurrent use is not recommended. |
| Methotrexate | May be used together in adults with rheumatoid arthritis or psoriatic arthritis, but combination therapy may increase side effect risk in some patients. | Use only under close medical supervision with regular monitoring. |
| Sulfasalazine | Combined use may lower white blood cell counts. | Blood tests may be needed during treatment. |
| Live Vaccines | Live vaccines may increase the risk of infection while using Rymti. | Avoid live vaccines during treatment. |
| Diabetes Treatments | Some patients may experience low blood sugar after starting Rymti. | Blood sugar levels and diabetes treatment may need adjustment. |
| Alcohol | No direct alcohol interaction is listed, but alcohol may increase stress on the immune system or liver in some patients. | Ask your doctor before drinking alcohol regularly while using Rymti. |
Alternatives
| Drug Name | Generic Name | Drug Class | Key Difference from Rymti | Best For |
| Humira | adalimumab | TNF blocker | Another TNF blocker with different dosing schedules and approved uses. | Patients needing treatment for multiple inflammatory conditions, including Crohn’s disease or ulcerative colitis. |
| Enbrel | etanercept | TNF blocker | Reference biologic to Rymti with the same active ingredient. | Patients are looking for the original etanercept biologic treatment. |
| Skyrizi | risankizumab | Interleukin-23 inhibitor | Targets IL-23 instead of TNF-alpha and is given less frequently. | Adults with plaque psoriasis, psoriatic arthritis, Crohn’s disease, or ulcerative colitis. |
| Tremfya | guselkumab | Interleukin-23 inhibitor | Works on a different inflammation pathway than TNF blockers. | Patients with plaque psoriasis or psoriatic arthritis may need another biologic approach. |
| Stelara | ustekinumab | Interleukin-12 and Interleukin-23 inhibitor | Blocks different immune system proteins involved in inflammation. | Patients with psoriasis, psoriatic arthritis, Crohn’s disease, or ulcerative colitis. |
Buy Rymti Online From Canada: Cost & Coupons
Pharma Giant helps U.S. patients access Rymti from licensed Canadian pharmacies through a secure and convenient ordering process. Every order is reviewed to help ensure safe and appropriate treatment before shipment.
Why Order Rymti From Pharma Giant?
- Sourced from licensed Canadian pharmacies
- Licensed pharmacists review prescription orders
- Fast shipping available across the United States
- Cold-chain handling for temperature-sensitive injections
- Simple ordering process with clear pricing information
- Ability to order up to a 3-month supply when prescribed
- Support from experienced pharmacy professionals
Rymti Coupon Code
Use code PGSAVE10 at checkout to receive 10% off your first Rymti order.
How to Order?
| Step 1: Search for your Rymti on the website, choose the correct strength and quantity, then add it to your cart.
Step 2: Enter your contact details, shipping address, and payment information. Create an account if you are a new customer or log in if you already have one. Step 3: If your order includes prescription Rymti, upload it directly to the site, email it, or fax it. Over-the-counter items do not require a prescription. Use PGSAVE10 to claim your 10% discount on your first order. |
Pharma Giant’s Guarantee
Pharma Giant works with trusted Canadian pharmacy partners to provide access to prescription treatments while maintaining safety and quality standards. All prescription orders are reviewed before dispensing, and temperature-sensitive products such as Rymti are packaged carefully for shipment.
Frequently Asked Questions
Buying Rymti from Canada
FDA-Prescription, Off-Label Information, and Limitations
Dosage & Administration
Adverse Reactions
Food & Drug Interactions
Storage & Travel
Drug Comparison
Disclaimer
Pharma Giant provides medical information to help you better understand medications and medical conditions.This content is for informational use only and does not replace advice from a licensed medical practitioner. Consult your doctor or pharmacist before starting or changing any medication. All our partners follow strict safety standards set by their country’s health authorities to make sure you receive safe and high-quality medications.





